Copyright © Inderes 2011 - present. All rights reserved.
Logga in för att få aviseringar
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Qlife Holding AB: Qlife has successfully verified the biomarkers related to the previously announced LOI

2025-02-21 09:00
Qlife Holding

Qlife is pleased to announce that, in collaboration with Hipro Biotechnology, the company has successfully verified biomarkers related to the LOI with a top-20 global pharma company that was announced on January 28th.  

On 28 January 2025, Qlife signed a Letter of Intent (LOI) with a top-20 global pharmaceutical company to explore potential commercial collaborations. Among the key criteria outlined in the LOI was Qlife's ability to test and integrate specific biomarkers into the Egoo Health platform. The company has now successfully verified these biomarkers, generating positive data. This confirmation demonstrates that the biomarkers covered in the LOI are compatible with the Egoo Health platform, reinforcing the feasibility of their integration.

"We look forward to presenting these data and expect that this will further advance discussions toward a partnership. As always, further validation of the biomarkers is required, and other parameters still need to be confirmed. However, it is very positive that the biomarkers have been fundamentally proven on the platform."- says Thomas Warthoe, CEO Qlife.

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.